ArticleFrontiers in oncology2020

Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case Report.

Cirino Botta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.